MSI ovarian cancers exhibited a significantly higher number of PD-L1+ intratumoural immune cells compared to MSS ovarian cancers, while PD-L1 expression was not different in tumors, irrespectively from their MMR status (30). This evidence concerns the gene CD274 and ovarian carcinoma.